详情页

资源类型：

文章类型：

作者：

Wei, Bo[1,2,3,4,5,6,7,8,9] * ; Xing, Xiaojing[1,2,3,4,5,6,7,8,9] ; Li, Ziyu[1,2,3,4,5,6,7,8,9] ; Han, Quanli[1,2,3,4,5,6,7,8,9] ; Hao, Yingxue[1,2,3,4,5,6,7,8,9] ; Zhou, Jing[1,2,3,4,5,6,7,8,9] ; Zhang, Yuzi[1,2,3,4,5,6,7,8,9] ; Zhao, Jing[1,2,3,4,5,6,7,8,9] ; Cai, Shangli[1,2,3,4,5,6,7,8,9] ; Gu, Yanhong[1,2,3,4,5,6,7,8,9] ; Chen, Tufeng[1,2,3,4,5,6,7,8,9] ;

机构： [1]The Third affiliated hospital, Sun Yat-Sen University, Guangzhou, China [2]Liaoning Cancer Hospital and Institute, Shenyang, China [3]Peking University Cancer Hospital and Institute, Beijing, China [4]Chinese PLA General Hospital, Beijing, China [5]Southwest Hospital, Chongqing, China [6]Peking University People's Hospital, Beijing, China [7]The Medical Department, 3D Medicines Inc., Shanghai, China [8]The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [9]Department of Gastrointestinal Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

中科院分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2019]版：

Q1 ONCOLOGY

最新[2024]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]The Third affiliated hospital, Sun Yat-Sen University, Guangzhou, China [2]Liaoning Cancer Hospital and Institute, Shenyang, China [3]Peking University Cancer Hospital and Institute, Beijing, China [4]Chinese PLA General Hospital, Beijing, China [5]Southwest Hospital, Chongqing, China [6]Peking University People's Hospital, Beijing, China [7]The Medical Department, 3D Medicines Inc., Shanghai, China [8]The First Affiliated Hospital of Nanjing Medical University, Nanjing, China [9]Department of Gastrointestinal Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Tumor mutation burden and immunogenicity in gastric cancer with HER2 alterations.

文献详情